Surgical Sphincteroplasty Market Synopsis

Surgical Sphincteroplasty Market Size Was Valued at USD 3.78 Billion in 2023, and is Projected to Reach USD 7.25 Billion by 2032, Growing at a CAGR of 7.5% From 2024-2032.

Surgical Sphincteroplasty is a medical procedure used to repair or reconstruct a damaged or weakened anal sphincter muscle. This muscle, located at the end of the digestive tract, helps control bowel movements by opening and closing the anus. Surgical sphincteroplasty is typically performed to treat conditions such as anal sphincter tears, fecal incontinence, or other injuries to the anal sphincter.

• Surgical sphincteroplasty is a procedure commonly used in colorectal surgery to repair or reconstruct damaged or weakened anal sphincter muscles. Surgical sphincteroplasty is a procedure used to repair obstetric anal sphincter injuries, such as those caused by childbirth, fecal incontinence, rectovaginal fistulas, rectal prolapse, chronic anal fissures, and anorectal malformations. It aims to restore the integrity and function of the anal sphincter muscles, improving continence.
• Surgical sphincteroplasty is performed in individuals suffering from fecal incontinence due to sphincter dysfunction or damage, rectovaginal fistulas, rectal prolapse, chronic anal fissures, and infants born with underdeveloped or malformed anal sphincter muscles. The procedure can help restore bowel control, reduce episodes of fecal incontinence, and prevent recurrence of anal fissures. Surgical sphincteroplasty is often required to repair injuries caused by childbirth, especially in women experiencing fecal incontinence. This procedure can improve the quality of life by restoring bowel control and allowing patients to regain confidence.
• Advancements in surgical techniques have made sphincteroplasty procedures more effective and less invasive. As awareness of fecal incontinence grows, more patients seek medical help. As the aging population becomes more common, there is a growing need for effective treatments. Healthcare providers are adopting a multidisciplinary approach, including dietary changes, pelvic floor exercises, medications, and surgical interventions.

Surgical Sphincteroplasty Market Trend Analysis

The severity of symptoms experienced by the patient

• Patients with severe fecal incontinence, characterized by the inability to control bowel movements, may opt for surgical sphincteroplasty when conservative treatments have failed to provide adequate relief. Severe fecal incontinence can significantly impact a patient's quality of life, leading to embarrassment, social isolation, and decreased confidence.
• Some Women may experience severe symptoms such as persistent fecal incontinence or difficulty controlling bowel movements due to a tear in the anal sphincter muscles (OASIS). The severity of symptoms, including the frequency and severity of incontinence episodes, may prompt the need for surgical repair to restore normal sphincter function and improve quality of life.
• The severity of symptoms associated with a rectovaginal fistula, such as fecal or gas passage through the vagina, pain, and recurrent infections, can influence the decision to undergo surgical sphincteroplasty. Larger fistulas or those causing significant symptoms may require surgical repair to close the abnormal connection between the rectum and vagina and restore continence.
• The severity and persistence of these symptoms may necessitate surgical intervention, including sphincteroplasty, to widen the anal canal and alleviate discomfort. Patients with chronic anal fissures may experience severe symptoms such as intense anal pain, bleeding, and difficulty with bowel movements. When conservative treatments fail to provide long-term relief, surgical sphincteroplasty may be considered to repair underlying sphincter muscle damage, promote healing, and prevent the recurrence of symptoms.

Restraint

Complications and Long-Term Effects

• Surgical sphincteroplasty is a procedure that can treat various conditions affecting the anal sphincter muscles. However, it can lead to potential complications such as infection, bleeding, anesthesia risks, damage to surrounding structures, urinary incontinence, persistent symptoms, and long-term effects. Infection can occur at the surgical site, which can be mitigated with proper preoperative preparation and postoperative care.
• Excessive bleeding may require additional intervention. Anesthesia risks can cause allergic reactions or adverse effects on vital organs. Damage to surrounding structures, nerves, or blood vessels can also lead to complications. Some patients may experience persistent symptoms, such as fecal incontinence or difficulty with bowel movements.
• Long-term effects include scar tissue formation, recurrence of symptoms, changes in bowel habits, and psychological impact. Patients may require ongoing medical monitoring to assess the procedure's effectiveness and address any complications. It is crucial for patients to discuss these risks with their healthcare provider and to receive thorough preoperative and postoperative care.

Opportunity

Treatment of Chronic Anal Fissures

• Surgical sphincteroplasty is a promising treatment for chronic anal fissures due to its ability to address underlying sphincter muscle dysfunction. This dysfunction can impair blood flow to the anal canal, delay healing, and contribute to fissure recurrence. Surgical sphincteroplasty releases or relaxes hypertonic sphincter muscles, reducing pressure on the fissure and promoting healing.
• Surgical sphincteroplasty also promotes healing by repairing damaged or weakened anal sphincter muscles, improving blood flow to the affected area. Surgical sphincteroplasty can prevent recurrence by restoring normal sphincter function, reducing the risk of fissure recurrence, and improving long-term outcomes.
• Surgical sphincteroplasty can complement conservative treatments by addressing the underlying muscle pathology, enhancing the effectiveness of other therapeutic interventions. Moreover, it can significantly improve the quality of life for patients suffering from chronic anal fissures by promoting fissure healing and reducing symptoms like pain and bleeding.

Challenge

Risk of Fissure Recurrence

• Fissure recurrence in surgical sphincteroplasty is a challenge due to underlying factors such as ongoing sphincter spasm, persistent constipation, and inflammatory bowel disease. Incomplete healing, alterations to anal sphincter tone, and patient compliance with post-operative care and lifestyle modifications can also increase the risk of fissure recurrence. Adherence to recommended dietary changes, bowel habits adjustments, and post-operative care instructions can also contribute to ongoing issues and increase the likelihood of fissure recurrence.
• Secondary conditions like obesity, diabetes, or autoimmune disorders can also impact the success of surgical sphincteroplasty and increase the risk of fissure recurrence. Additionally, scar tissue formation at the surgical site can affect tissue flexibility and function, potentially leading to complications like stricture or narrowing of the anal canal.

Surgical Sphincteroplasty Market Segment Analysis:

Surgical Sphincteroplasty Market Segmented based on Type and end-users.

By Type, Direct Apposition Sphincteroplasty segment is expected to dominate the market during the forecast period

• Direct apposition sphincteroplasty is a surgical technique used to repair damaged or weakened anal sphincter muscles, improving bowel control and symptom relief. It is widely accepted for treating conditions like obstetric anal sphincter injuries, traumatic sphincter injuries, and chronic anal fissures.
• The technique involves minimal tissue disruption, preserving healthy tissue, leading to faster recovery times, reduced pain, and fewer complications. It is often less costly than more complex surgical techniques, making it a cost-effective option for healthcare providers and patients.
• Direct apposition sphincteroplasty can be performed as a standalone procedure or in conjunction with other techniques, depending on the patient's needs and underlying condition. Studies show high success rates in improving bowel control and reducing symptoms like fecal incontinence or chronic anal fissures.

By End-User, Hospitals segment held the largest share of 56.2% in 2023

• Hospitals are essential for performing complex surgical procedures like sphincteroplasty, thanks to their specialized facilities, multidisciplinary teams, access to resources like diagnostic imaging and post-operative care services, and emergency services. They also provide a safe environment for patients to recover from complications.
• Many insurance plans require surgical procedures to be performed in a hospital setting, ensuring proper monitoring and access to emergency services. Hospitals also serve as teaching institutions for healthcare professionals, providing advanced training in surgical techniques and contributing to ongoing research and innovation in the field. Overall, hospitals play a crucial role in providing comprehensive care for patients undergoing sphincteroplasty.

Surgical Sphincteroplasty Market Regional Insights:

North America is Expected to Dominate the Market Over the Forecast Period

• North America is a major market for surgical interventions for pelvic floor disorders, such as fecal incontinence, chronic anal fissures, and obstetric anal sphincter injuries. The region's advanced healthcare infrastructure, including well-equipped hospitals and specialized surgical centers, provides patients with access to advanced diagnostic and treatment facilities.
• Technological advancements in pelvic floor surgery, such as advanced techniques and minimally invasive approaches, attract patients seeking high-quality care. North America's research and development ecosystem, including academic institutions and medical device companies, contributes to the development of new surgical techniques and devices. High healthcare spending and widespread insurance coverage also facilitate access to surgical interventions.
• Patient awareness and education about pelvic floor disorders and treatment options are growing, driving demand for surgical interventions. The North American market is dominated by leading medical device manufacturers, pharmaceutical companies, and healthcare providers specializing in pelvic floor disorders.

Surgical Sphincteroplasty Market Top Key Players:

• Johnson & Johnson (US)
• Boston Scientific Corporation (US)
• Avanos Medical, Inc. (US)
• Cantel Medical Corp. (US)
• Stryker Corporation (US)
• Abbott Laboratories (US)
• CONMED Corporation (US)
• Intuitive Surgical, Inc. (US)
• Teleflex Incorporated (US)
• Cook Medical LLC (US)
• Becton, Dickinson and Company (BD) (US)
• Zimmer Biomet Holdings, Inc. (US)
• Merit Medical Systems, Inc. (US)
• Ethicon, Inc. (US)
• Cardinal Health, Inc. (US)
• Edwards Lifesciences Corporation (US)
• B. Braun Melsungen AG (Germany)
• Karl Storz SE & Co. KG (Germany)
• Smith & Nephew plc (UK)
• Medtronic plc (Ireland)
• Mindray Medical International Limited (China)
• Olympus Corporation (Japan)
• Fujifilm Holdings Corporation (Japan)
• Terumo Corporation (Japan)
• Essity AB (Sweden), and other major players

Key Industry Developments in the Surgical Sphincteroplasty Market:

• In January 2024, Boston Scientific Corporation announced a definitive agreement to acquire Axonics, Inc. a publicly traded medical technology company primarily focused on the development and commercialization of differentiated devices to treat urinary and bowel dysfunction.
• In July 2023, Teleflex Incorporated, a leading global provider of medical technologies, announced a definitive agreement to acquire privately-held Palette Life Sciences AB. The acquisition will expand the Teleflex Interventional Urology portfolio, which includes the UroLift System, to include Non-Animal Stabilized Hyaluronic Acid spacer, and tissue bulking products that improve patient outcomes in urology and urogynecology disorders, colorectal conditions, and radiation oncology procedures.

1. INTRODUCTION
   1. RESEARCH OBJECTIVES
   2. RESEARCH METHODOLOGY
   3. RESEARCH PROCESS
   4. SCOPE AND COVERAGE
      1. Market Definition
      2. Key Questions Answered
   5. MARKET SEGMENTATION
2. EXECUTIVE SUMMARY
3. MARKET OVERVIEW
4. GROWTH OPPORTUNITIES BY SEGMENT
5. MARKET LANDSCAPE
   1. PORTER’S FIVE FORCES ANALYSIS
      1. Bargaining Power Of Supplier
      2. Threat Of New Entrants
      3. Threat Of Substitutes
      4. Competitive Rivalry
      5. Bargaining Power Among Buyers
   2. INDUSTRY VALUE CHAIN ANALYSIS
   3. MARKET DYNAMICS
      1. Drivers
      2. Restraints
      3. Opportunities
      4. Challenges
   4. MARKET TREND ANALYSIS
   5. REGULATORY LANDSCAPE
   6. PESTLE ANALYSIS
   7. PRICE TREND ANALYSIS
   8. PATENT ANALYSIS
   9. TECHNOLOGY EVALUATION
   10. MARKET IMPACT OF THE RUSSIA-UKRAINE WAR
       1. Geopolitical Market Disruptions
       2. Supply Chain Disruptions
       3. Instability in Emerging Markets
   11. ECOSYSTEM
6. SURGICAL SPHINCTEROPLASTY MARKET BY TYPE (2017-2030)
   1. SURGICAL SPHINCTEROPLASTY MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. DIRECT APPOSITION SPHINCTEROPLASTY
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. OVERLAPPING SPHINCTEROPLASTY
   5. PARTIAL SPHINCTEROPLASTY
   6. INJECTION SPHINCTEROPLASTY
7. SURGICAL SPHINCTEROPLASTY MARKET BY END USER (2017-2030)
   1. SURGICAL SPHINCTEROPLASTY MARKET SNAPSHOT AND GROWTH ENGINE
   2. MARKET OVERVIEW
   3. HOSPITALS
      1. Introduction And Market Overview
      2. Historic And Forecasted Market Size in Value (2017 – 2030F)
      3. Historic And Forecasted Market Size in Volume (2017 – 2030F)
      4. Key Market Trends, Growth Factors And Opportunities
      5. Geographic Segmentation Analysis
   4. SPECIALTY CLINICS
8. COMPANY PROFILES AND COMPETITIVE ANALYSIS
   1. COMPETITIVE LANDSCAPE
      1. Competitive Positioning
      2. Surgical Sphincteroplasty Market Share By Manufacturer (2022)
      3. Industry BCG Matrix
      4. Heat Map Analysis
      5. Mergers & Acquisitions
   2. JOHNSON & JOHNSON (US)
      1. Company Overview
      2. Key Executives
      3. Company Snapshot
      4. Role of the Company in the Market
      5. Sustainability and Social Responsibility
      6. Operating Business Segments
      7. Product Portfolio
      8. Business Performance (Production Volume, Sales Volume, Sales Margin, Production Capacity, Capacity Utilization Rate)
      9. Key Strategic Moves And Recent Developments
      10. SWOT Analysis
   3. BOSTON SCIENTIFIC CORPORATION (US)
   4. AVANOS MEDICAL, INC. (US)
   5. CANTEL MEDICAL CORP. (US)
   6. STRYKER CORPORATION (US)
   7. ABBOTT LABORATORIES (US)
   8. CONMED CORPORATION (US)
   9. INTUITIVE SURGICAL, INC. (US)
   10. TELEFLEX INCORPORATED (US)
   11. COOK MEDICAL LLC (US)
   12. BECTON, DICKINSON AND COMPANY (BD) (US)
   13. ZIMMER BIOMET HOLDINGS, INC. (US)
   14. MERIT MEDICAL SYSTEMS, INC. (US)
   15. ETHICON, INC. (US)
   16. CARDINAL HEALTH, INC. (US)
   17. EDWARDS LIFESCIENCES CORPORATION (US)
   18. B. BRAUN MELSUNGEN AG (GERMANY)
   19. KARL STORZ SE & CO. KG (GERMANY)
   20. SMITH & NEPHEW PLC (UK)
   21. MEDTRONIC PLC (IRELAND)
   22. MINDRAY MEDICAL INTERNATIONAL LIMITED (CHINA)
   23. OLYMPUS CORPORATION (JAPAN)
   24. FUJIFILM HOLDINGS CORPORATION (JAPAN)
   25. TERUMO CORPORATION (JAPAN)
   26. ESSITY AB (SWEDEN)
9. GLOBAL SURGICAL SPHINCTEROPLASTY MARKET BY REGION
   1. OVERVIEW
   2. NORTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Type
      4. Historic And Forecasted Market Size By End User
      5. Historic And Forecasted Market Size By Country
         1. USA
         2. Canada
         3. Mexico
   3. EASTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Russia
         2. Bulgaria
         3. The Czech Republic
         4. Hungary
         5. Poland
         6. Romania
         7. Rest Of Eastern Europe
   4. WESTERN EUROPE
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Germany
         2. United Kingdom
         3. France
         4. The Netherlands
         5. Italy
         6. Spain
         7. Rest Of Western Europe
   5. ASIA PACIFIC
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. China
         2. India
         3. Japan
         4. South Korea
         5. Malaysia
         6. Thailand
         7. Vietnam
         8. The Philippines
         9. Australia
         10. New-Zealand
         11. Rest Of APAC
   6. MIDDLE EAST & AFRICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Turkey
         2. Bahrain
         3. Kuwait
         4. Saudi Arabia
         5. Qatar
         6. UAE
         7. Israel
         8. South Africa
   7. SOUTH AMERICA
      1. Key Market Trends, Growth Factors And Opportunities
      2. Key Manufacturers
      3. Historic And Forecasted Market Size By Segments
      4. Historic And Forecasted Market Size By Country
         1. Brazil
         2. Argentina
         3. Rest of South America
10. INVESTMENT ANALYSIS
11. ANALYST VIEWPOINT AND CONCLUSION
    1. Recommendations and Concluding Analysis
    2. Potential Market Strategies

LIST OF TABLES

TABLE 001. EXECUTIVE SUMMARY
TABLE 002. SURGICAL SPHINCTEROPLASTY MARKET BARGAINING POWER OF SUPPLIERS
TABLE 003. SURGICAL SPHINCTEROPLASTY MARKET BARGAINING POWER OF CUSTOMERS
TABLE 004. SURGICAL SPHINCTEROPLASTY MARKET COMPETITIVE RIVALRY
TABLE 005. SURGICAL SPHINCTEROPLASTY MARKET THREAT OF NEW ENTRANTS
TABLE 006. SURGICAL SPHINCTEROPLASTY MARKET THREAT OF SUBSTITUTES
TABLE 007. SURGICAL SPHINCTEROPLASTY MARKET BY PRODUCT TYPE
TABLE 008. SYSTEMS MARKET OVERVIEW (2016-2028)
TABLE 009. DISPOSABLES MARKET OVERVIEW (2016-2028)
TABLE 010. SURGICAL SPHINCTEROPLASTY MARKET BY TECHNOLOGY TYPE
TABLE 011. DRILLS MARKET OVERVIEW (2016-2028)
TABLE 012. BURS MARKET OVERVIEW (2016-2028)
TABLE 013. LASERS MARKET OVERVIEW (2016-2028)
TABLE 014. PIEZO TOMES MARKET OVERVIEW (2016-2028)
TABLE 015. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 016. SURGICAL SPHINCTEROPLASTY MARKET BY APPLICATION
TABLE 017. PARTIAL KNEE REPLACEMENT MARKET OVERVIEW (2016-2028)
TABLE 018. TOTAL KNEE REPLACEMENT MARKET OVERVIEW (2016-2028)
TABLE 019. MIS FUSION MARKET OVERVIEW (2016-2028)
TABLE 020. ENDOCHONDRAL OSSIFICATION MARKET OVERVIEW (2016-2028)
TABLE 021. OTHERS MARKET OVERVIEW (2016-2028)
TABLE 022. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 023. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET, BY TECHNOLOGY TYPE (2016-2028)
TABLE 024. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET, BY APPLICATION (2016-2028)
TABLE 025. N SURGICAL SPHINCTEROPLASTY MARKET, BY COUNTRY (2016-2028)
TABLE 026. EUROPE SURGICAL SPHINCTEROPLASTY MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 027. EUROPE SURGICAL SPHINCTEROPLASTY MARKET, BY TECHNOLOGY TYPE (2016-2028)
TABLE 028. EUROPE SURGICAL SPHINCTEROPLASTY MARKET, BY APPLICATION (2016-2028)
TABLE 029. SURGICAL SPHINCTEROPLASTY MARKET, BY COUNTRY (2016-2028)
TABLE 030. ASIA PACIFIC SURGICAL SPHINCTEROPLASTY MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 031. ASIA PACIFIC SURGICAL SPHINCTEROPLASTY MARKET, BY TECHNOLOGY TYPE (2016-2028)
TABLE 032. ASIA PACIFIC SURGICAL SPHINCTEROPLASTY MARKET, BY APPLICATION (2016-2028)
TABLE 033. SURGICAL SPHINCTEROPLASTY MARKET, BY COUNTRY (2016-2028)
TABLE 034. MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 035. MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET, BY TECHNOLOGY TYPE (2016-2028)
TABLE 036. MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET, BY APPLICATION (2016-2028)
TABLE 037. SURGICAL SPHINCTEROPLASTY MARKET, BY COUNTRY (2016-2028)
TABLE 038. SOUTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET, BY PRODUCT TYPE (2016-2028)
TABLE 039. SOUTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET, BY TECHNOLOGY TYPE (2016-2028)
TABLE 040. SOUTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET, BY APPLICATION (2016-2028)
TABLE 041. SURGICAL SPHINCTEROPLASTY MARKET, BY COUNTRY (2016-2028)
TABLE 042. MEDTRONIC: SNAPSHOT
TABLE 043. MEDTRONIC: BUSINESS PERFORMANCE
TABLE 044. MEDTRONIC: PRODUCT PORTFOLIO
TABLE 045. MEDTRONIC: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 045. HILL-ROM SERVICES INC.: SNAPSHOT
TABLE 046. HILL-ROM SERVICES INC.: BUSINESS PERFORMANCE
TABLE 047. HILL-ROM SERVICES INC.: PRODUCT PORTFOLIO
TABLE 048. HILL-ROM SERVICES INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 048. B. BRAUN: SNAPSHOT
TABLE 049. B. BRAUN: BUSINESS PERFORMANCE
TABLE 050. B. BRAUN: PRODUCT PORTFOLIO
TABLE 051. B. BRAUN: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 051. NOVO SURGICAL INC.: SNAPSHOT
TABLE 052. NOVO SURGICAL INC.: BUSINESS PERFORMANCE
TABLE 053. NOVO SURGICAL INC.: PRODUCT PORTFOLIO
TABLE 054. NOVO SURGICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 054. BECTON: SNAPSHOT
TABLE 055. BECTON: BUSINESS PERFORMANCE
TABLE 056. BECTON: PRODUCT PORTFOLIO
TABLE 057. BECTON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 057. DICKINSON: SNAPSHOT
TABLE 058. DICKINSON: BUSINESS PERFORMANCE
TABLE 059. DICKINSON: PRODUCT PORTFOLIO
TABLE 060. DICKINSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 060. AND COMPANY: SNAPSHOT
TABLE 061. AND COMPANY: BUSINESS PERFORMANCE
TABLE 062. AND COMPANY: PRODUCT PORTFOLIO
TABLE 063. AND COMPANY: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 063. SALIX PHARMACEUTICAL INC.: SNAPSHOT
TABLE 064. SALIX PHARMACEUTICAL INC.: BUSINESS PERFORMANCE
TABLE 065. SALIX PHARMACEUTICAL INC.: PRODUCT PORTFOLIO
TABLE 066. SALIX PHARMACEUTICAL INC.: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 066. JOHNSON & JOHNSON: SNAPSHOT
TABLE 067. JOHNSON & JOHNSON: BUSINESS PERFORMANCE
TABLE 068. JOHNSON & JOHNSON: PRODUCT PORTFOLIO
TABLE 069. JOHNSON & JOHNSON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 069. MCKESSON PELVALON: SNAPSHOT
TABLE 070. MCKESSON PELVALON: BUSINESS PERFORMANCE
TABLE 071. MCKESSON PELVALON: PRODUCT PORTFOLIO
TABLE 072. MCKESSON PELVALON: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 072. OTHER MAJOR PLAYERS: SNAPSHOT
TABLE 073. OTHER MAJOR PLAYERS: BUSINESS PERFORMANCE
TABLE 074. OTHER MAJOR PLAYERS: PRODUCT PORTFOLIO
TABLE 075. OTHER MAJOR PLAYERS: KEY STRATEGIC MOVES AND DEVELOPMENTS

LIST OF FIGURES

FIGURE 001. YEARS CONSIDERED FOR ANALYSIS
FIGURE 002. SCOPE OF THE STUDY
FIGURE 003. SURGICAL SPHINCTEROPLASTY MARKET OVERVIEW BY REGIONS
FIGURE 004. PORTER'S FIVE FORCES ANALYSIS
FIGURE 005. BARGAINING POWER OF SUPPLIERS
FIGURE 006. COMPETITIVE RIVALRYFIGURE 007. THREAT OF NEW ENTRANTS
FIGURE 008. THREAT OF SUBSTITUTES
FIGURE 009. VALUE CHAIN ANALYSIS
FIGURE 010. PESTLE ANALYSIS
FIGURE 011. SURGICAL SPHINCTEROPLASTY MARKET OVERVIEW BY PRODUCT TYPE
FIGURE 012. SYSTEMS MARKET OVERVIEW (2016-2028)
FIGURE 013. DISPOSABLES MARKET OVERVIEW (2016-2028)
FIGURE 014. SURGICAL SPHINCTEROPLASTY MARKET OVERVIEW BY TECHNOLOGY TYPE
FIGURE 015. DRILLS MARKET OVERVIEW (2016-2028)
FIGURE 016. BURS MARKET OVERVIEW (2016-2028)
FIGURE 017. LASERS MARKET OVERVIEW (2016-2028)
FIGURE 018. PIEZO TOMES MARKET OVERVIEW (2016-2028)
FIGURE 019. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 020. SURGICAL SPHINCTEROPLASTY MARKET OVERVIEW BY APPLICATION
FIGURE 021. PARTIAL KNEE REPLACEMENT MARKET OVERVIEW (2016-2028)
FIGURE 022. TOTAL KNEE REPLACEMENT MARKET OVERVIEW (2016-2028)
FIGURE 023. MIS FUSION MARKET OVERVIEW (2016-2028)
FIGURE 024. ENDOCHONDRAL OSSIFICATION MARKET OVERVIEW (2016-2028)
FIGURE 025. OTHERS MARKET OVERVIEW (2016-2028)
FIGURE 026. NORTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 027. EUROPE SURGICAL SPHINCTEROPLASTY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 028. ASIA PACIFIC SURGICAL SPHINCTEROPLASTY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 029. MIDDLE EAST & AFRICA SURGICAL SPHINCTEROPLASTY MARKET OVERVIEW BY COUNTRY (2016-2028)
FIGURE 030. SOUTH AMERICA SURGICAL SPHINCTEROPLASTY MARKET OVERVIEW BY COUNTRY (2016-2028)